0001730728-19-000001.txt : 20191227 0001730728-19-000001.hdr.sgml : 20191227 20191227145453 ACCESSION NUMBER: 0001730728-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191227 DATE AS OF CHANGE: 20191227 EFFECTIVENESS DATE: 20191227 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ZETAGEN THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001730728 IRS NUMBER: 473365449 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-356559 FILM NUMBER: 191313440 BUSINESS ADDRESS: STREET 1: 841 EAST FAYETTE STREET CITY: SYRACUSE STATE: NY ZIP: 13210 BUSINESS PHONE: 401-699-9402 MAIL ADDRESS: STREET 1: 841 EAST FAYETTE STREET CITY: SYRACUSE STATE: NY ZIP: 13210 FORMER COMPANY: FORMER CONFORMED NAME: FUSOLOGICS, INC. DATE OF NAME CHANGE: 20180213 FORMER COMPANY: FORMER CONFORMED NAME: FUSOLOGICS INC. DATE OF NAME CHANGE: 20180207 D 1 primary_doc.xml X0708 D LIVE 0001730728 ZETAGEN THERAPEUTICS, INC. 841 EAST FAYETTE STREET SYRACUSE NY NEW YORK 13210 401-699-9402 DELAWARE FUSOLOGICS, INC. FUSOLOGICS INC. Corporation true 2015 Nikhil Thakur, MD 6 Warwick Circle Andover MA MASSACHUSETTS 01890 Executive Officer Director Peter B. Finn 53 State Sreet Boston MA MASSACHUSETTS 02109 Executive Officer Joe C Loy 1250 Cactus Rio Drive Weatherford TX TEXAS 76087 Executive Officer Director Pharmaceuticals Decline to Disclose 06b false 2019-12-13 false true false 5000 8500000 840000 7660000 false 4 0 0 0 true Some of the proceeds of the offering will be used for executive compensation. false ZETAGEN THERAPEUTICS, INC. PETER B. FINN PETER B. FINN SECRETARY 2019-12-27